Weekly insulin is coming to Israel — with a rival close behind
FDA approves Eli Lilly’s once-weekly insulin, Onswik, for adults with type 2 diabetes; Novo Nordisk’s rival weekly insulin, also approved in the US, is expected to reach Israel within weeks
We haven't written up this one. Ynetnews Culture has the full story — the link below goes straight to it.